PTI-428

· Proteostasis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PTI-428, covering 2018-05-24 to 2020-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis [Phase 1, Phase 2]

See pricing